Clinical Trials in Salt Lake City

Showing 13001-13020 of 14,325 trials

CAFE Comparison of Atypicals in First Episode of Psychosis

NCT00034892

The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.

SchizophreniaPsychotic DisordersMental Health+1 more

AstraZenecaStarted Mar 2002

Stanford, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +23 more locations

COMPLETEDPhase 2< 1 mile

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

NCT00206245

The primary objective is to compare the efficacy between three doses of AZD0865 (25, 50 and 75 mg). The secondary objectives are to compare the efficacy between the three doses of AZD0865 and esomeprazole 40 mg and to evaluate the safety and tolerability of AZD0865.

GERD With Erosive Esophagitis

AstraZeneca1,400 participantsStarted May 2004

Alabaster, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +199 more locations

CAFE Comparison of Atypicals in First Episode of Psychosis

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

Find Trials by Condition in Salt Lake City

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

S9912 Combination Chemo in Stage III Ovarian Cancer,

Iressa Expanded Access Program (EAP)

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

A Study in Erectile Dysfunction

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Dialysis Catheter Comparative Clinical Trial

Seroquel in Bipolar Depression Versus SSRI

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Study of Antidepressants in Parkinson's Disease

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)